# NK Cells Infusion for Advanced Malignancies

> **NCT03619954** · PHASE1 · UNKNOWN · sponsor: **Anhui Provincial Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Immunotherapy

## Interventions

- **BIOLOGICAL:** NK cells infusion

## Key facts

- **NCT ID:** NCT03619954
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2019-07-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03619954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03619954, "NK Cells Infusion for Advanced Malignancies". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03619954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*